Bayer Animal Health, a pharmaceutical and animal health company, and feed additive supplier Dr. Eckel announced the completed registration of Latibon Plus ME in Indonesia. The multifunctional acidifier, developed and manufactured by Dr. Eckel and supplied to the feed industry in Southeast Asia by Bayer Animal Health, will be available to customers in Indonesia in 2013. Indonesia is the seventh country in Asia to approve Latibon Plus ME for distribution.
After two years of work from both companies, the registration license was issued by the Ministry of Agriculture, which approved Latibon Plus ME for pigs, duck, chicken and cattle. Additional claims for shrimp and fish feed were registered with the Ministry of Marine Affairs and Fisheries and are estimated to obtain approval in Indonesia in 2014.
Latibon Plus ME combines organic and inorganic acids and their salts to reduce the buffering capacity in feed, Dr. Eckel says.
"Improved hygiene optimized buffering capacity and a better digestibility -- these are key performances factors supporting healthy growth in young animals. Furthermore, Latibon Plus ME improves the intestinal flora and protects the animals against diarrhea," said Dr. Bernhard Eckel, vice president of Dr. Eckel.
Further registration for the product is currently underway in China and Malaysia.
After two years of work from both companies, the registration license was issued by the Ministry of Agriculture, which approved Latibon Plus ME for pigs, duck, chicken and cattle. Additional claims for shrimp and fish feed were registered with the Ministry of Marine Affairs and Fisheries and are estimated to obtain approval in Indonesia in 2014.
Latibon Plus ME combines organic and inorganic acids and their salts to reduce the buffering capacity in feed, Dr. Eckel says.
"Improved hygiene optimized buffering capacity and a better digestibility -- these are key performances factors supporting healthy growth in young animals. Furthermore, Latibon Plus ME improves the intestinal flora and protects the animals against diarrhea," said Dr. Bernhard Eckel, vice president of Dr. Eckel.
Further registration for the product is currently underway in China and Malaysia.
No comments:
Post a Comment